산모 정신건강 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 지역별 전망, 예측(2023-2030년) - (적응 질환별, 치료법별, 지역별, 기업별)

Maternal Mental Health Market - Global Maternal Mental Health Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Disease Indication Coverage, By Therapy Coverage, By Geographic Coverage and By Company)

US $ 4,995 ￦ 7,030,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,956,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,919,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 산모 정신건강 시장 규모는 2023-2030년 CAGR 28%라는 견고한 성장을 배경으로, 2030년말까지 400억 달러라는 대폭적인 평가를 달성할 기세입니다. 이러한 전례 없는 성장은 산모 사망률 감소를 위한 정부 자금 증가, 산후 우울증 발생률의 급격한 증가, 인식 개선 프로그램 확대, 산모 정신건강 관련 실천을 강화하기 위한 지속적인 노력 등 몇 가지 중요한 요인에 기인합니다.

산모 정신건강 시장의 급속한 성장은 긍정적인 상환 시나리오, 산후 우울증(PPD) 유병률 증가, 광범위한 인식 개선 구상의 구현, 견고하고 신뢰할 수있는 의료 인프라의 존재와 같은 매우 중요한 요소의 조합에 의해 지원됩니다.

산후우울증은 산후 산모의 정신적 안녕에 심각한 영향을 미치는 질환으로, 그 광범위한 발생과 심각한 영향으로 인해 산모 정신건강 분야에서 가장 큰 시장 점유율을 차지하고 있습니다.

대인관계치료(IPT)는 인간관계에 기반한 스트레스 요인을 해결하고 주산기 산모의 행복을 증진시키는 효과가 있는 것으로 알려지면서 산모 정신건강 시장의 주요 치료 접근법으로 부상하고 있습니다.

북미는 전문 치료, 상담 서비스 및 지원 그룹에 대한 접근성 강화의 혜택을 누리며 산모 정신건강 시장의 선두를 지키고 있습니다. 이 지역의 첨단화된 의료 인프라와 산모 정신건강에 대한 적극적인 접근 방식은 이 지역의 선도적 지위에 기여하고 있습니다.

아시아태평양은 산모 정신건강에 대한 인식이 높아지면서 가장 빠르게 성장하는 시장으로 부상하고 있습니다. 이 지역의 경제 성장으로 인해 의료 인프라가 개선되고, 의료 시설에 대한 접근성이 높아지면서 여성 건강에 대한 관심이 높아지고 있습니다.

세계의 산모 정신건강 시장에 대해 조사했으며, 시장의 개요와 적응 질환별, 치료법별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장의 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아의 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 산모 정신건강 시장 전망, 2018-2030년

• 세계의 산모 정신건강 시장 전망, 적응 질환별, 금액(10억 달러), 2018-2030년
• 세계의 산모 정신건강 시장 전망, 치료법별, 금액(10억 달러), 2018-2030년
• 세계의 산모 정신건강 시장 전망, 지역별, 금액(10억 달러), 2018-2030년

제4장 북미의 산모 정신건강 시장 전망, 2018-2030년

제5장 유럽의 산모 정신건강 시장 전망, 2018-2030년

제6장 아시아태평양의 산모 정신건강 시장 전망, 2018-2030년

제7장 라틴아메리카의 산모 정신건강 시장 전망, 2018-2030년

제8장 중동 및 아프리카의 산모 정신건강 시장 전망, 2018-2030년

제9장 경쟁 구도

• 질환 적응과 용도 히트맵
• 제조업체와 용도 히트맵
• 기업의 시장 점유율 분석, 2022년
• 경쟁력 대시보드
• 기업 개요
  • Pfizer, Inc.
  • Lipocine, Inc.
  • Viatris Inc.
  • GlaxoSmithKline plc
  • Alembic Pharmaceuticals Limited
  • Mallinckrodt, Inc.
  • Sage Therapeutics, Inc.
  • Bold Health
  • Bausch Health Companies Inc.
  • Magellan Health, Inc.

제10장 부록

KSA

영문 목차

영문목차

Global Maternal Mental Health Market Poised for Remarkable Growth, Projected to Reach US$40 Billion by 2030.

The global maternal mental health market is on track to achieve a substantial valuation of US$40 billion by the close of 2030, driven by a robust compound annual growth rate (CAGR) of 28% during the period from 2023 to 2030. This unprecedented growth is attributed to several key factors, including increased government funding aimed at reducing maternal mortality, a surge in the incidence of postpartum depression, expanding awareness programs, and ongoing efforts to enhance practices related to maternal mental health.

Market Insights in Brief

The maternal mental health market's rapid expansion is underpinned by a combination of pivotal drivers, including positive reimbursement scenarios, a rising prevalence of postpartum depression (PPD), the implementation of widespread awareness initiatives, and the presence of a robust and reliable healthcare infrastructure.

Postpartum depression, a condition with significant implications for the mental well-being of postpartum mothers, commands the largest market share in the maternal mental health sector due to its widespread occurrence and profound impact.

Interpersonal therapy (IPT) has emerged as a leading therapeutic approach in the maternal mental health market, known for its effectiveness in addressing relationship-based stressors and enhancing maternal well-being during the perinatal period.

Regional Dynamics

North America remains at the forefront of the maternal mental health market, benefiting from enhanced accessibility to specialized care, counseling services, and support groups. The region's advanced healthcare infrastructure and proactive approach towards maternal mental health have contributed to its leadership position.

Asia Pacific, experiencing a surge in awareness about maternal mental health issues, is emerging as the fastest-growing market. The region's economic growth has led to improved healthcare infrastructure, increased access to medical facilities, and a growing emphasis on women's health.

Growth Drivers

• 1. Growing Government Funds Targeting Reduced Maternal Mortality

Government investments in mental health services and support for pregnant and postpartum women have played a pivotal role in reducing the risk of maternal mental health disorders. These funds have led to the expansion of maternal mental health services, including early detection, counseling, specialized clinics, and awareness campaigns, thereby reducing stigma and encouraging more women to seek help during pregnancy and postpartum periods.

• 2. Growing Incidences of Postpartum Depression

The rising prevalence of postpartum depression, coupled with improved screening and detection measures, has resulted in a higher demand for maternal mental health services. Timely intervention for postpartum depression is recognized as crucial to prevent long-term impacts on both mother and child well-being, further driving market growth.

Challenges

Mental Health Workforce Shortage

Despite the growing demand for mental health services during the perinatal period, a shortage of qualified experts remains a significant constraint. This scarcity leads to long wait times for appointments, limited access to specialized treatment, and delayed interventions, potentially affecting the health outcomes of pregnant and postpartum women.

Competitive Landscape

Key players in the maternal mental health market include: Lipocine, Inc., Pfizer, Inc., Viatris, Inc., Bold Health, GlaxoSmithKline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt, Inc., Sage Therapeutics, Inc., Bausch Health Companies Inc., and Magellan Health, Inc.

The global maternal mental health market's remarkable growth trajectory underscores its pivotal role in safeguarding the well-being of mothers and the health and development of their children. As governments, healthcare providers, and the private sector continue to invest in this critical healthcare segment, the market is poised to make substantial strides in the years ahead.

Table of Contents

1. Executive Summary

• 1.1. Global Maternal Mental Health Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2022
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. Covid-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Maternal Mental Health Market Outlook, 2018 - 2030

• 3.1. Global Maternal Mental Health Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2030
  • 3.1.1. Key Highlights
    • 3.1.1.1. Postpartum Depression
    • 3.1.1.2. Dysthymia
    • 3.1.1.3. Pregnancy and Postpartum General Anxiety
    • 3.1.1.4. Pregnancy and Postpartum OCD
    • 3.1.1.5. Birth-Related PTSD
    • 3.1.1.6. Others
• 3.2. Global Maternal Mental Health Market Outlook, by Therapy, Value (US$ Bn), 2018 - 2030
  • 3.2.1. Key Highlights
    • 3.2.1.1. Antidepressants
      • 3.2.1.1.1. Selective serotonin reuptake inhibitors (SSRIs)
      • 3.2.1.1.2. Tricyclic antidepressants (TCAs)
      • 3.2.1.1.3. Other
    • 3.2.1.2. Interpersonal Psychotherapy (IPT)
    • 3.2.1.3. Cognitive Behavioural Therapy (CBT)
    • 3.2.1.4. Other
• 3.3. Global Maternal Mental Health Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
  • 3.3.1. Key Highlights
    • 3.3.1.1. North America
    • 3.3.1.2. Europe
    • 3.3.1.3. Asia Pacific
    • 3.3.1.4. Latin America
    • 3.3.1.5. Middle East & Africa

4. North America Maternal Mental Health Market Outlook, 2018 - 2030

• 4.1. North America Maternal Mental Health Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2030
  • 4.1.1. Key Highlights
    • 4.1.1.1. Postpartum Depression
    • 4.1.1.2. Dysthymia
    • 4.1.1.3. Pregnancy and Postpartum General Anxiety
    • 4.1.1.4. Pregnancy and Postpartum OCD
    • 4.1.1.5. Birth-Related PTSD
    • 4.1.1.6. Others
• 4.2. North America Maternal Mental Health Market Outlook, by Therapy, Value (US$ Bn), 2018 - 2030
  • 4.2.1. Key Highlights
    • 4.2.1.1. Antidepressants
      • 4.2.1.1.1. Selective serotonin reuptake inhibitors (SSRIs)
      • 4.2.1.1.2. Tricyclic antidepressants (TCAs)
      • 4.2.1.1.3. Other
    • 4.2.1.2. Interpersonal Psychotherapy (IPT)
    • 4.2.1.3. Cognitive Behavioural Therapy (CBT)
    • 4.2.1.4. Other
  • 4.2.2. Market Attractiveness Analysis
• 4.3. North America Maternal Mental Health Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 4.3.1. Key Highlights
    • 4.3.1.1. U.S. Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 4.3.1.2. U.S. Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 4.3.1.3. Canada Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 4.3.1.4. Canada Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Maternal Mental Health Market Outlook, 2018 - 2030

• 5.1. Europe Maternal Mental Health Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2030
  • 5.1.1. Key Highlights
    • 5.1.1.1. Postpartum Depression
    • 5.1.1.2. Dysthymia
    • 5.1.1.3. Pregnancy and Postpartum General Anxiety
    • 5.1.1.4. Pregnancy and Postpartum OCD
    • 5.1.1.5. Birth-Related PTSD
    • 5.1.1.6. Others
• 5.2. Europe Maternal Mental Health Market Outlook, by Therapy, Value (US$ Bn), 2018 - 2030
  • 5.2.1. Key Highlights
    • 5.2.1.1. Antidepressants
      • 5.2.1.1.1. Selective serotonin reuptake inhibitors (SSRIs)
      • 5.2.1.1.2. Tricyclic antidepressants (TCAs)
      • 5.2.1.1.3. Other
    • 5.2.1.2. Interpersonal Psychotherapy (IPT)
    • 5.2.1.3. Cognitive Behavioural Therapy (CBT)
    • 5.2.1.4. Other
  • 5.2.2. BPS Analysis/Market Attractiveness Analysis
• 5.3. Europe Maternal Mental Health Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 5.3.1. Key Highlights
    • 5.3.1.1. Germany Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.2. Germany Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 5.3.1.3. U.K. Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.4. U.K. Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 5.3.1.5. France Maternal Mental Health Market By Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.6. France Maternal Mental Health Market By Therapy, Value (US$ Bn), 2018 - 2030
    • 5.3.1.7. Italy Maternal Mental Health Market By Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.8. Italy Maternal Mental Health Market By Therapy, Value (US$ Bn), 2018 - 2030
    • 5.3.1.9. Turkey Maternal Mental Health Market By Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.10. Turkey Maternal Mental Health Market By Therapy, Value (US$ Bn), 2018 - 2030
    • 5.3.1.11. Russia Maternal Mental Health Market By Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.12. Russia Maternal Mental Health Market By Therapy, Value (US$ Bn), 2018 - 2030
    • 5.3.1.13. Rest Of Europe Maternal Mental Health Market By Disease Indication, Value (US$ Bn), 2018 - 2030
    • 5.3.1.14. Rest Of Europe Maternal Mental Health Market By Therapy, Value (US$ Bn), 2018 - 2030
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Maternal Mental Health Market Outlook, 2018 - 2030

• 6.1. Asia Pacific Maternal Mental Health Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2030
  • 6.1.1. Key Highlights
    • 6.1.1.1. Postpartum Depression
    • 6.1.1.2. Dysthymia
    • 6.1.1.3. Pregnancy and Postpartum General Anxiety
    • 6.1.1.4. Pregnancy and Postpartum OCD
    • 6.1.1.5. Birth-Related PTSD
    • 6.1.1.6. Others
• 6.2. Asia Pacific Maternal Mental Health Market Outlook, by Therapy, Value (US$ Bn), 2018 - 2030
  • 6.2.1. Key Highlights
    • 6.2.1.1. Antidepressants
      • 6.2.1.1.1. Selective serotonin reuptake inhibitors (SSRIs)
      • 6.2.1.1.2. Tricyclic antidepressants (TCAs)
      • 6.2.1.1.3. Other
    • 6.2.1.2. Interpersonal Psychotherapy (IPT)
    • 6.2.1.3. Cognitive Behavioural Therapy (CBT)
    • 6.2.1.4. Other
  • 6.2.2. BPS Analysis/Market Attractiveness Analysis
• 6.3. Asia Pacific Maternal Mental Health Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 6.3.1. Key Highlights
    • 6.3.1.1. China Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 6.3.1.2. China Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 6.3.1.3. Japan Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 6.3.1.4. Japan Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 6.3.1.5. South Korea Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 6.3.1.6. South Korea Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 6.3.1.7. India Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 6.3.1.8. India Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 6.3.1.9. Southeast Asia Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 6.3.1.10. Southeast Asia Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 6.3.1.11. Rest of Asia Pacific Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 6.3.1.12. Rest of Asia Pacific Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Maternal Mental Health Market Outlook, 2018 - 2030

• 7.1. Latin America Maternal Mental Health Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2030
  • 7.1.1. Key Highlights
    • 7.1.1.1. Postpartum Depression
    • 7.1.1.2. Dysthymia
    • 7.1.1.3. Pregnancy and Postpartum General Anxiety
    • 7.1.1.4. Pregnancy and Postpartum OCD
    • 7.1.1.5. Birth-Related PTSD
    • 7.1.1.6. Others
• 7.2. Latin America Maternal Mental Health Market Outlook, by Therapy, Value (US$ Bn), 2018 - 2030
  • 7.2.1. Key Highlights
    • 7.2.1.1. Antidepressants
      • 7.2.1.1.1. Selective serotonin reuptake inhibitors (SSRIs)
      • 7.2.1.1.2. Tricyclic antidepressants (TCAs)
      • 7.2.1.1.3. Other
    • 7.2.1.2. Interpersonal Psychotherapy (IPT)
    • 7.2.1.3. Cognitive Behavioural Therapy (CBT)
    • 7.2.1.4. Other
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Latin America Maternal Mental Health Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 7.3.1. Key Highlights
    • 7.3.1.1. Brazil Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 7.3.1.2. Brazil Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 7.3.1.3. Mexico Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 7.3.1.4. Mexico Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 7.3.1.5. Argentina Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 7.3.1.6. Argentina Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 7.3.1.7. Rest of Latin America Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 7.3.1.8. Rest of Latin America Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Maternal Mental Health Market Outlook, 2018 - 2030

• 8.1. Middle East & Africa Maternal Mental Health Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2030
  • 8.1.1. Key Highlights
    • 8.1.1.1. Postpartum Depression
    • 8.1.1.2. Dysthymia
    • 8.1.1.3. Pregnancy and Postpartum General Anxiety
    • 8.1.1.4. Pregnancy and Postpartum OCD
    • 8.1.1.5. Birth-Related PTSD
    • 8.1.1.6. Others
• 8.2. Middle East & Africa Maternal Mental Health Market Outlook, by Therapy, Value (US$ Bn), 2018 - 2030
  • 8.2.1. Key Highlights
    • 8.2.1.1. Antidepressants
      • 8.2.1.1.1. Selective serotonin reuptake inhibitors (SSRIs)
      • 8.2.1.1.2. Tricyclic antidepressants (TCAs)
      • 8.2.1.1.3. Other
    • 8.2.1.2. Interpersonal Psychotherapy (IPT)
    • 8.2.1.3. Cognitive Behavioural Therapy (CBT)
    • 8.2.1.4. Other
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Middle East & Africa Maternal Mental Health Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 8.3.1. Key Highlights
    • 8.3.1.1. GCC Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 8.3.1.2. GCC Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 8.3.1.3. South Africa Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 8.3.1.4. South Africa Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 8.3.1.5. Egypt Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 8.3.1.6. Egypt Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 8.3.1.7. Nigeria Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 8.3.1.8. Nigeria Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
    • 8.3.1.9. Rest of Middle East & Africa Maternal Mental Health Market by Disease Indication, Value (US$ Bn), 2018 - 2030
    • 8.3.1.10. Rest of Middle East & Africa Maternal Mental Health Market by Therapy, Value (US$ Bn), 2018 - 2030
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Disease Indication vs Application Heatmap
• 9.2. Manufacturer vs Application Heatmap
• 9.3. Company Market Share Analysis, 2022
• 9.4. Competitive Dashboard
• 9.5. Company Profiles
  • 9.5.1. Pfizer, Inc.
    • 9.5.1.1. Company Overview
    • 9.5.1.2. Product Portfolio
    • 9.5.1.3. Financial Overview
    • 9.5.1.4. Business Strategies and Development
  • 9.5.2. Lipocine, Inc.
    • 9.5.2.1. Company Overview
    • 9.5.2.2. Product Portfolio
    • 9.5.2.3. Financial Overview
    • 9.5.2.4. Business Strategies and Development
  • 9.5.3. Viatris Inc.
    • 9.5.3.1. Company Overview
    • 9.5.3.2. Product Portfolio
    • 9.5.3.3. Financial Overview
    • 9.5.3.4. Business Strategies and Development
  • 9.5.4. GlaxoSmithKline plc
    • 9.5.4.1. Company Overview
    • 9.5.4.2. Product Portfolio
    • 9.5.4.3. Financial Overview
    • 9.5.4.4. Business Strategies and Development
  • 9.5.5. Alembic Pharmaceuticals Limited
    • 9.5.5.1. Company Overview
    • 9.5.5.2. Product Portfolio
    • 9.5.5.3. Financial Overview
    • 9.5.5.4. Business Strategies and Development
  • 9.5.6. Mallinckrodt, Inc.
    • 9.5.6.1. Company Overview
    • 9.5.6.2. Product Portfolio
    • 9.5.6.3. Financial Overview
    • 9.5.6.4. Business Strategies and Development
  • 9.5.7. Sage Therapeutics, Inc.
    • 9.5.7.1. Company Overview
    • 9.5.7.2. Product Portfolio
    • 9.5.7.3. Financial Overview
    • 9.5.7.4. Business Strategies and Development
  • 9.5.8. Bold Health
    • 9.5.8.1. Company Overview
    • 9.5.8.2. Product Portfolio
    • 9.5.8.3. Financial Overview
    • 9.5.8.4. Business Strategies and Development
  • 9.5.9. Bausch Health Companies Inc.
    • 9.5.9.1. Company Overview
    • 9.5.9.2. Product Portfolio
    • 9.5.9.3. Financial Overview
    • 9.5.9.4. Business Strategies and Development
  • 9.5.10. Magellan Health, Inc.
    • 9.5.10.1. Company Overview
    • 9.5.10.2. Product Portfolio
    • 9.5.10.3. Financial Overview
    • 9.5.10.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

관련자료